Amicogen, Inc. — Investor Relations & Filings
Amicogen, Inc. is an industrial biotechnology company specializing in the development and production of specialty enzymes and proteins. The company operates across three primary business areas: Enzyme and Biopharmaceuticals, Healthcare and Nutrition, and Bioprocess and CDMO (Contract Development and Manufacturing Organization) services. Leveraging its proprietary enzyme technology, Amicogen creates innovative solutions for the biopharmaceutical, food, and cosmetics industries. The healthcare division develops and manufactures functional food ingredients and nutritional products. The company also provides bioprocess solutions, including protein purification resins and comprehensive CDMO services to support the biopharmaceutical sector.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-04 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-05-04 | Korean | |
| [기재정정]사업보고서 (2024.12) | 2026-04-30 | Korean | |
| [기재정정]분기보고서 (2025.03) | 2026-04-30 | Korean | |
| [기재정정]반기보고서 (2025.06) | 2026-04-30 | Korean | |
| [기재정정]분기보고서 (2025.09) | 2026-04-30 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40830949 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-04 | Korean | ||
| 40830871 | 주식등의대량보유상황보고서(일반) | 2026-05-04 | Korean | ||
| 39073552 | [기재정정]사업보고서 (2024.12) | 2026-04-30 | Korean | ||
| 39073409 | [기재정정]분기보고서 (2025.03) | 2026-04-30 | Korean | ||
| 39073184 | [기재정정]반기보고서 (2025.06) | 2026-04-30 | Korean | ||
| 39073033 | [기재정정]분기보고서 (2025.09) | 2026-04-30 | Korean | ||
| 39072792 | [기재정정]사업보고서 (2025.12) | 2026-04-30 | Korean | ||
| 39066980 | [기재정정]사업보고서 (2025.12) | 2026-04-30 | Korean | ||
| 37959259 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차) | 2026-04-28 | Korean | ||
| 37939432 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제4회차) | 2026-04-28 | Korean | ||
| 37939311 | [기재정정]전환사채(해외전환사채포함)발행후만기전사채취득 (제5회차) | 2026-04-28 | Korean | ||
| 34568163 | 전환가액의조정 (제6회차) | 2026-04-15 | Korean | ||
| 33095696 | 정기주주총회결과 | 2026-03-31 | Korean | ||
| 33012316 | 사업보고서 (2025.12) | 2026-03-23 | Korean | ||
| 33010934 | 감사보고서제출 | 2026-03-23 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
LUMOS DIAGNOSTICS HOLDINGS LIMITED
Develops rapid point-of-care diagnostics and contract manuf…
|
LDX | AU | Manufacturing |
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
Produces APIs and dosage forms for digestive, respiratory, …
|
002793 | CN | Manufacturing |
|
Lupin Ltd
Global pharma firm producing generic and branded formulatio…
|
LUPIN | IN | Manufacturing |
|
LUSHANG FREDA PHARMACEUTICAL CO.,LTD.
Global leader in sodium hyaluronate production for medical,…
|
600223 | CN | Manufacturing |
|
Luye Pharma Group Limited
Global enterprise developing innovative CNS drugs via advan…
|
2186 | HK | Manufacturing |
|
Lyell Immunopharma, Inc.
A clinical-stage company developing CAR T-cell therapies fo…
|
LYEL | US | Manufacturing |
|
Lyka Labs Ltd.
Develops and manufactures pharmaceutical formulations, APIs…
|
LYKALABS | IN | Manufacturing |
|
Lyra Therapeutics, Inc.
Clinical-stage biotech developing sinonasal implants to tre…
|
LYRA | US | Manufacturing |
|
Lytix Biopharma AS
Clinical-stage immuno-oncology company developing oncolytic…
|
LYTIX | NO | Manufacturing |
|
Mabion S.A.
A CDMO providing end-to-end services for protein-based biot…
|
MAB | PL | Manufacturing |
Amicogen, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16981/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16981 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16981 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16981 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16981}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Amicogen, Inc. (id: 16981)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.